Joseph Senesac

Acting Chief Technology Officer at NKILT Therapeutics

Joseph Senesac is an accomplished biotechnology leader with extensive experience in technical operations, quality assurance, and process development within the cell and gene therapy sectors. Currently serving as Acting Chief Technology Officer at NKILT Therapeutics, Inc., Joseph leads technical operations at a startup focused on novel NK cell technologies. As a consultant with JHS Biotech Consulting LLC, Joseph has provided expertise to numerous advanced therapy companies, assisting with CMC, QA, and strategic evaluations that have resulted in significant investments and operational enhancements. Joseph's previous roles include Senior Vice President of Technical Operations and Quality at Bellicum Pharmaceuticals, where oversight spanned manufacturing, quality control, and product development across various therapies. Educational qualifications include a BA in Chemistry and Economics from Knox College, a B.S. in Biology from the University of Houston, and an MBA from the University of Colorado Colorado Springs.

Links

Previous companies

Promega logo
Bellicum Pharmaceuticals logo

Org chart


Teams

This person is not in any teams